NEW YORK - A physicians group running a study of the use of Spectranetics Corp.'s lasers with nitinol stents has voluntarily stopped enrollment in the study to address safety concerns, the company said Monday.
NEW YORK - A physicians group running a study of the use of Spectranetics Corp.'s lasers with nitinol stents has voluntarily stopped enrollment in the study to address safety concerns, the company said Monday.
